Analyst recommendations: Carrefour, Sanofi, Saint-Gobain, Elior, Ipsen, Vicat, Ubisoft, Getlink, Virbac, Technip Energies


Six changes in recommendations to note this Monday on the side of analysts, on Carrefour, Elior, Getlink, Technip Energies, Virbac and Ubisoft. Several price adjustments to note as well.

CROSSROADS

Analyst recommendations: Carrefour, Sanofi, Saint-Gobain, Elior, Ipsen, Vicat | Photo credits: © Barbe Lionel, Carrefour

Crossroads. Berenberg goes to “buy”, against “hold” previously, with a price target raised from 18.80 to 23.10 euros.

Sanofi. Jefferies raises its target price to 135 euros, against 120 euros.

Saint Gobain. Deutsche Bank is aiming for 8 euros less, or 70 euros.

Elior. Deutsche Bank lowers its recommendation to “hold” against “buy”, with a target of 3.1 euros, against 8.1 euros previously.

Ipsen. Morgan Stanley is targeting 90 euros, against 82 euros previously.

Vicat. Barclays lowers its price target from 50 euros to 40 euros.

Technip Energies. Societe Generale raises its recommendation to “hold” to “buy” to target 20 euros, against 14.60 previously.

Ubisoft. Goldman Sachs goes from “neutral” to “sell” and is targeting 40 euros, against 52 previously.

Getlink. HSBC downgrades its recommendation to “hold” against “buy”, but raises its price target from 15.25 to 16.40.

Virbac. Oddo BHF goes to “outperformance”, against “neutral” previously, and aims for a price of 400 euros.


Invest




Source link -91